The growing cost of brand-name prescription drugs (BNPD) -- FDA-approved drug products that typically have patent protection -- is a concern for patients, payers, and providers of health care -- particularly when price increases are large and occur suddenly. A 2008 congressional hearing drew attention to some small market prescription drugs that had an extraordinary price increase -- 100% or more at a single point in time. This report examined extraordinary price increases for BNPD. It examined the: (1) frequency of extraordinary price increases for BNPD from 2000 to 2008; (2) characteristics of the BNPD that had extraordinary price increases; and (3) factors that contributed to the extraordinary price increases experienced by these BNPD. Illustrations.AppendixII:Brand-name PrescriptionDrugs withanExtraordinaryPrice increase, 2000to 2008 Appendix II: Brand-name Prescription Drugs with an Extraordinary Price Increase, 2000 to 2008 Using Thomson Reutersa#39; Red Book, 1 we calculated anbsp;...
|Title||:||Brand-New Prescription Drug Pricing|
|Author||:||John E. Dicken|
|Publisher||:||DIANE Publishing - 2010-06|